Explore › Outcome › Glucose Metabolism Disorders
Outcome

Glucose Metabolism Disorders

Also known as: Disorder of glucose metabolism Disorder of glucose metabolism (disorder) Disorder, Glucose Metabolic Disorder, Glucose Metabolism Disorders, Glucose Metabolic Disorders, Glucose Metabolism GLUCOSE METAB DIS Glucose Metabolic Disorder Glucose Metabolic Disorders Glucose Metabolism Disorder Glucose Metabolism Disorders Glucose metabolism and metabolic syndrome components +4 more
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Targeted glucose and metabolic screening1
conditions
Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome1
populations
Postmenopausal Women1
studys
PMC30744071

Findings (27)

None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →

Papers (1)